Investegate |Novacyt S.A. Announcements | Novacyt S.A.: Holdings in Company
Investegate announcements from Novacyt S.A., Holdings in Company
Stay updated with breaking news from Foster Mitchell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Novacyt S.A., Holdings in Company
Chronocort ® is a modified-release preparation of hydrocortisone that has been specifically designed to mimic the circadian rhythm of cortisol when given in a twice-a-day "toothbrush" regimen (last thing at night before sleep and first thing in the morning on waking) to control androgen excess and chronic fatigue in patients with diseases of cortisol deficiency. The first planned indication for Chronocort ® is Congenital Adrenal Hyperplasia (CAH) in adults and adolescents. Chronocort ® has been extensively studied in human subjects having completed four Phase I trials, a Phase II tri...